Yield10 Biosciences shares are trading lower after the company announced pricing of a $3.7 million public offering.
Portfolio Pulse from Benzinga Newsdesk
Yield10 Biosciences has announced the pricing of a $3.7 million public offering, leading to a decrease in its share price.
August 11, 2023 | 12:32 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Yield10 Biosciences' shares are trading lower after the company announced a $3.7 million public offering.
The announcement of a public offering often leads to a decrease in share price as it dilutes the value of existing shares. This is likely the reason for the drop in Yield10 Biosciences' share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100